Myopia Control Combined PBM With Myopic Defocus Lens in Children
Key facts
- Who runs it
- Beijing Airdoc Technology Co., Ltd.
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 304 people, planned
- Started
- 12 Dec 2022
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 4 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- PBM
- Peripheral defocus spectacles
- Single vision spectacles
- Record updated
- 9 March 2023
Who can take part
- Age
- 6 years to 13 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- Informed consent by the supervision of the children
- 6~13 years old (including both the 6 and 13)
- SE range: -0.50~-5.50D
- Astigmatism <=2.00D
- BCVA >=0.8
- Anisometropia <=1.50D
- Confirmed to no use of other myopia control intervention
Who cannot take part
- Ocular lesions to effect vision or diseases (such as cataract, glaucoma, marcular pathology, cornea lesions, uveitis, retina detachment, congential opitc abnormal and etc.)
- Systom disease: immune disease, central nerve system, Down syndrome, asthma, severe cardiopulmonary abnormal, severe liver and renal dysfunction
- Halo, glare, toutic, ADHD, psoriasis
- Squint, ocular lesion or acute imflammation
- Other myopia control interventions within recent 3 month such as atropine, device, orthokeratology, multi-focus soft lens, multi-function spectacles
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To study the efficacy of myopi control with two methods: low lever red light and peripheral defocus spectacles with four groups and design with prospective, double-blind, randimized, and with control for 6 month.
The 4 groups in the trial
- PBM therapy + SVSTreatment being tested
Low lever red light therapy with single vision spectacles
Treatment: PBM and Single vision spectacles
- Peripheral defocus spectaclesTreatment being tested
a spectacles with special design with peripheral myopic defocus to control myopia progression
- PBM +Peripheral defocus spectaclesTreatment being tested
Low lever red light therapy with a spectacles with special design with peripheral myopic defocus to control myopia progression
Treatment: PBM and Peripheral defocus spectacles
- ControlPlacebo, for comparison
single vision spectacles only as the control
Treatment: Single vision spectacles
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Myopia Control Combined PBM With Myopic Defocus Lens in Children: Double-blind RCT for 6 Month
- Criteria questions
- Built from NCT05756959, who can take part
- Record updated
- 9 March 2023